Rhaeos
Medical device company developing non-invasive thermal sensors to monitor cerebrospinal fluid flow for hydrocephalus patients, enabling early detection of shunt malfunction.
Notes
Rhaeos is a medical device company developing non-invasive thermal sensors to monitor cerebrospinal fluid (CSF) flow in patients with hydrocephalus. The company spun out of Northwestern University and is based in Chicago, Illinois.
Hydrocephalus is a condition where excess cerebrospinal fluid builds up in the brain, typically treated with a shunt to drain the fluid. However, shunt malfunctions are common and difficult to diagnose, often requiring expensive imaging and hospital visits. Rhaeos's FlowSense technology provides a non-invasive way to monitor shunt function, enabling early detection of malfunctions and reducing unnecessary hospital visits.
The company is currently in clinical stage development and is part of the Portal Innovations portfolio.
Team
- Anna Lisa Somera - Chief Executive Officer
- LinkedIn: linkedin.com/in/annalisasomera
- John Rogers, Ph.D. - Scientific Founder (Professor at Northwestern University)
Additional Research Findings
- Portfolio company of Portal Innovations
- Stage: Clinical
- University Spinout: Northwestern University
- FlowSense non-invasive thermal sensor technology
- Monitors cerebrospinal fluid flow
- Addresses shunt malfunction detection in hydrocephalus
- Chicago, Illinois headquarters
Sources
Investors
| Name | Location | Type | Stages | Portfolio |
|---|---|---|---|---|
| Portal Innovations | US | biotech-focused | - | 13 |